Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Carlsmed

Biotech & Life Sciences · United States · Founded 2018 · IPO 2025 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$149M
Market cap · Apr/2026
Revenue
$51M
Latest reported FY

Investors

5 investors on Carlsmed's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 2 investors entered at this stage
The Cove Fund
Wavemaker Three-Sixty Health
Series A 2 investors entered at this stage
U.S. Venture Partners
The Vertical Group
Series B+ 1 investor entered at this stage
B Capital

Global footprint

Where Carlsmed has talent and traffic

AI talent share
0.7% of workforce is AI talent
(1 of 137 staff)
Core AI10.73%
Other AI00%
Non-AI workforce13699.27%
Web traffic by country
4.5K monthly visits
across markets
🇺🇸 United States93.3%
🇮🇳 India6.7%
Top 2 markets shown

See Carlsmed on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo